Cipla Shares Under Pressure As 4 Brokerages Cut Target Prices In 2 Days - What's Worrying Analysts?

Cipla shares succumbed to selling pressure on Wednesday, after four brokerages reduced their target prices for the drug maker in two days. Analysts say concerns persist among investors about the pharma company's key manufacturing facilities.